Why Every Diabetologist Needs More Than HbA1c to Protect Their Patients’ Feet
When most diabetic patients walk into your clinic, you already know what the first lab test will show: HbA1c. For decades, this number has been the gold standard for understanding long-term glycemic control. Yet, every diabetologist knows that a good HbA1c does not guarantee that the patient is safe from complications.
One of the most devastating complications of diabetes hides silently below the ankle — the diabetic foot. The World Health Organization estimates that every 30 seconds, a lower-limb amputation takes place somewhere in the world due to diabetes. And here is the hard truth: most amputations are preventable with early detection and smart intervention.
So why are we still losing so many patients to avoidable foot complications? The answer lies in one word: screening.
The Gap Between HbA1c and the Foot
HbA1c tells you about blood sugar control, but it doesn’t reveal what’s happening in the patient’s nerves, vessels, or skin. A patient with “perfect” HbA1c could still be walking on high pressure zones, silent ulcers, or advanced neuropathy without realizing it.
By the time visible signs like calluses, wounds, or infections appear, it’s often too late. That’s when physicians, surgeons, and diabetologists are left with limited options, sometimes leading to amputation.
This is why AI-powered, smart diagnostic tools are changing the way foot care is delivered.
Early Risk Detections: The Doctor’s Best Weapon
The only way to prevent diabetic foot complications is to catch them before they progress. This means detecting:
- Small & large fiber neuropathy before numbness and burning pain become disabling.
- Vascular compromise through ABI vascular screening and Doppler studies before ischemia sets in.
- High pressure zones with a Plantar Pressure System before they evolve into ulcers.
- Subtle deformities and calluses with DIME 2D Imaging before skin breaks down.
Each of these tools offers doctors a chance to act early, not react late.
The Power of an Integrated Diabetic Foot Lab
What if all these diagnostic tools could be brought together into one seamless platform? That’s the vision behind the Afora Advanced Diabetic Foot Lab — designed by clinicians, for clinicians.
Plantar Pressure System
Maps dynamic high pressure zones during gait.
Helps physicians, diabetologists, endocrinologists and orthotists understand risk zones for ulcers.
DIME 2D Imaging
Captures visual documentation of deformities, calluses, wounds, or healing progress.
Provides objective before/after evidence for both doctors and patients.
5 in 1 Neuropathy Analyzer
Screens small & large fiber neuropathy using vibration, hot & cold perception, skin temperature, and monofilament tests.
Portable and AI integrated — making neuropathy testing as routine as checking BP.
ABI Vascular Screening with Doppler
Detects early vascular disease in diabetic patients.
Critical for surgeons before deciding on wound care or revascularization.
Custom Footwear & Insoles
Converts diagnostic data into personalized solutions.
Protects vulnerable areas, offloads risk zones, and ensures long-term compliance.
Together, these tools transform diabetic foot care from fragmented testing into a dynamic, AI powered ecosystem.
A Case Every Doctor Recognizes
A 52-year-old patient with type 2 diabetes and an HbA1c of 7.2% visits your OPD. Clinically stable, no major complaints. On examination, you notice minor calluses on the sole — nothing alarming. Traditionally, you would note it, give footwear advice, and move on.
But with smart diagnostic tools, you discover:
- Neuropathy Analyzer: Early small fiber neuropathy.
- Plantar Pressure System: A hotspot under the first metatarsal, indicating high pressure zones.
- ABI Vascular Screening: Mild arterial compromise, not symptomatic yet.
- DIME 2D Imaging: Clear documentation of skin thickening for baseline record.
Now, your approach changes completely:
- You prescribe custom footwear & insoles to offload risk zones.
- You advise closer follow-up with the vascular team.
- You educate the patient with AI-generated reports that show the risks visually.
Result? An ulcer prevented, an amputation avoided, and a patient’s trust earned.
Why This Matters for Every Specialist
- For Diabetologists & Physicians: Adds depth beyond HbA1c, turns preventive screening into a routine.
- For Surgeons: Provides early data before wounds become surgical emergencies.
- For Hospitals: Positions them as centers of excellence, reduces medico-legal risks, and creates new revenue streams.
The Future: AI Powered Precision
What makes the Afora ecosystem different is not just the devices — it’s the AI powered integration.
- Reports are color-coded, automated, and patient-friendly.
- Doctors save time: trained staff can run tests, while doctors review results and focus on decision-making.
- Progress tracking is dynamic: every foot scan, every ABI, every neuropathy score builds a digital record for long-term monitoring.
This is where diabetes care is heading: precision, automation, and prevention.
Mission 2030: An Amputation-Free India
Every diabetologist knows the heartbreak of telling a patient their limb cannot be saved. With modern tools, these conversations don’t have to happen as often.
An HbA1c of 7 is good. But if the patient has neuropathy, vascular compromise, and unprotected pressure zones, that HbA1c means little.
With smart diagnostics like the 5 in 1 Neuropathy Analyzer, OHM 3000, OHM 12000, DIME 2D Imaging, and ABI vascular screening, we can move from reactive care to preventive care. Add custom footwear & insoles, and suddenly, diabetic foot becomes a manageable condition instead of a silent killer.
The future of diabetes care is clear: Every clinic, every hospital, every diabetologist needs more than HbA1c.